Page last updated: 2024-11-04

sulfadiazine and Dermatomyositis, Adult Type

sulfadiazine has been researched along with Dermatomyositis, Adult Type in 1 studies

Sulfadiazine: One of the short-acting SULFONAMIDES used in combination with PYRIMETHAMINE to treat toxoplasmosis in patients with acquired immunodeficiency syndrome and in newborns with congenital infections.
sulfadiazine : A sulfonamide consisting of pyrimidine with a 4-aminobenzenesulfonamido group at the 2-position.
diazine : The parent structure of the diazines.

Research Excerpts

ExcerptRelevanceReference
"We report a 59-year-old woman with severe dermatomyositis in association with high serum toxoplasma antibody titres who was successfully treated with pyrimethamine and sulphadiazine."3.68Dermatomyositis responding to treatment of associated toxoplasmosis. ( Allen, BR; Harland, CC; Marsden, JR; Vernon, SA, 1991)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Harland, CC1
Marsden, JR1
Vernon, SA1
Allen, BR1

Other Studies

1 other study available for sulfadiazine and Dermatomyositis, Adult Type

ArticleYear
Dermatomyositis responding to treatment of associated toxoplasmosis.
    The British journal of dermatology, 1991, Volume: 125, Issue:1

    Topics: Dermatomyositis; Drug Therapy, Combination; Female; Fundus Oculi; Hand; Humans; Middle Aged; Pyrimet

1991